AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
TUMOR-TARGETING WITH THE ANTI-CD44V6 MONOCLONAL-ANTIBODY BIWA-1 IN HEAD AND NECK-CANCER PATIENTS
Authors: STROOMER JGW ROOS JC QUAK JJ SPROLL M HEIDER KH KWAKKELSTEIN MO SNOW GB VANDONGEN GAMS
Citation: Jgw. Stroomer et al., TUMOR-TARGETING WITH THE ANTI-CD44V6 MONOCLONAL-ANTIBODY BIWA-1 IN HEAD AND NECK-CANCER PATIENTS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 21-21
[RE-186]-LABELED MOUSE AND CHIMERIC MONOCLONAL-ANTIBODY 323 A3 - A COMPARISON OF THE EFFICACY IN EXPERIMENTAL HUMAN OVARIAN-CANCER/
Authors: KIEVIT E VANGOG FB SCHLUPER HMM VANDONGEN GAMS PINEDO HM BOVEN E
Citation: E. Kievit et al., [RE-186]-LABELED MOUSE AND CHIMERIC MONOCLONAL-ANTIBODY 323 A3 - A COMPARISON OF THE EFFICACY IN EXPERIMENTAL HUMAN OVARIAN-CANCER/, Nuclear medicine and biology, 25(1), 1998, pp. 37-45
PERSPECTIVES OF COMBINED RADIOIMMUNOTHERAPY AND ANTI-EGFR ANTIBODY THERAPY FOR THE TREATMENT OF RESIDUAL HEAD AND NECK-CANCER
Authors: VANGOG FB BRAKENHOFF RH STIGTERVANWALSUM M SNOW GB VANDONGEN GAMS
Citation: Fb. Vangog et al., PERSPECTIVES OF COMBINED RADIOIMMUNOTHERAPY AND ANTI-EGFR ANTIBODY THERAPY FOR THE TREATMENT OF RESIDUAL HEAD AND NECK-CANCER, International journal of cancer, 77(1), 1998, pp. 13-18
SENSITIVE DETECTION OF HEAD AND NECK SQUAMOUS TUMOR-CELLS IN BONE-MARROW AND BLOOD BY MOLECULAR MARKERS
Authors: BRAKENHOFF RH STROOMER JWG VANDONGEN GAMS TENBRINK CBM SNOW GB
Citation: Rh. Brakenhoff et al., SENSITIVE DETECTION OF HEAD AND NECK SQUAMOUS TUMOR-CELLS IN BONE-MARROW AND BLOOD BY MOLECULAR MARKERS, British Journal of Cancer, 77, 1998, pp. 16-16
PROSPECTS FOR FUTURE STUDIES IN HEAD AND NECK-CANCER
Authors: VANDONGEN GAMS SNOW GB
Citation: Gams. Vandongen et Gb. Snow, PROSPECTS FOR FUTURE STUDIES IN HEAD AND NECK-CANCER, European journal of surgical oncology, 23(6), 1997, pp. 486-491
COMPARISON OF THE BIODISTRIBUTION AND THE EFFICACY OF MONOCLONAL-ANTIBODY 323 A3 LABELED WITH EITHER I-131 OR RE-186 IN HUMAN OVARIAN-CANCER XENOGRAFTS/
Authors: KIEVIT E VANGOG FB SCHUPER HMM VANDONGEN GAMS PINEDO HM BOVEN E
Citation: E. Kievit et al., COMPARISON OF THE BIODISTRIBUTION AND THE EFFICACY OF MONOCLONAL-ANTIBODY 323 A3 LABELED WITH EITHER I-131 OR RE-186 IN HUMAN OVARIAN-CANCER XENOGRAFTS/, International journal of radiation oncology, biology, physics, 38(4), 1997, pp. 813-823
SEQUENCE VARIATION IN THE MONOCLONAL-ANTIBODY-U36-DEFINED CD44V6 EPITOPE
Authors: VANHAL NLW VANDONGEN GAMS TENBRINK CBM HERRON JN SNOW GB BRAKENHOFF RH
Citation: Nlw. Vanhal et al., SEQUENCE VARIATION IN THE MONOCLONAL-ANTIBODY-U36-DEFINED CD44V6 EPITOPE, Cancer immunology and immunotherapy, 45(2), 1997, pp. 88-92
RAPID ELIMINATION OF MOUSE HUMAN CHIMERIC MONOCLONAL-ANTIBODIES IN NUDE-MICE/
Authors: VANGOG FB BRAKENHOFF RH SNOW GB VANDONGEN GAMS
Citation: Fb. Vangog et al., RAPID ELIMINATION OF MOUSE HUMAN CHIMERIC MONOCLONAL-ANTIBODIES IN NUDE-MICE/, Cancer immunology and immunotherapy, 44(2), 1997, pp. 103-111
DOSE RHENIUM-186-LABELING OF MONOCLONAL-ANTIBODIES FOR CLINICAL-APPLICATION - PITFALLS AND SOLUTIONS
Authors: VANGOG FB VISSER GWM STROOMER JWG ROOS JC SNOW GB VANDONGEN GAMS
Citation: Fb. Vangog et al., DOSE RHENIUM-186-LABELING OF MONOCLONAL-ANTIBODIES FOR CLINICAL-APPLICATION - PITFALLS AND SOLUTIONS, Cancer, 80(12), 1997, pp. 2360-2370
SELECTION OF MONOCLONAL-ANTIBODY E48 IGG OR U36 IGG FOR ADJUVANT RADIOIMMUNOTHERAPY IN HEAD AND NECK-CANCER PATIENTS
Authors: DEBREE R ROOS JC PLAIZIER MABD QUAK JJ VANKAMP GJ DENHOLLANDER W SNOW GB VANDONGEN GAMS
Citation: R. Debree et al., SELECTION OF MONOCLONAL-ANTIBODY E48 IGG OR U36 IGG FOR ADJUVANT RADIOIMMUNOTHERAPY IN HEAD AND NECK-CANCER PATIENTS, British Journal of Cancer, 75(7), 1997, pp. 1049-1060
SQUAMOUS-CELL CARCINOMA-ASSOCIATED ANTIGENS USED IN NOVEL STRATEGIES FOR THE DETECTION AND TREATMENT OF MINIMAL RESIDUAL HEAD AND NECK-CANCER
Authors: VANDONGEN GAMS BRAKENHOFF RM TENBRINK C VANGOG FB DEBREE R QUAK JJ SNOW GB
Citation: Gams. Vandongen et al., SQUAMOUS-CELL CARCINOMA-ASSOCIATED ANTIGENS USED IN NOVEL STRATEGIES FOR THE DETECTION AND TREATMENT OF MINIMAL RESIDUAL HEAD AND NECK-CANCER, Anticancer research, 16(4C), 1996, pp. 2409-2413
MONOCLONAL-ANTIBODIES LABELED WITH RE-186 USING THE MAG3 CHELATE - RELATIONSHIP BETWEEN THE NUMBER OF CHELATED GROUPS AND BIODISTRIBUTION CHARACTERISTICS
Authors: VANGOG FB VISSER GWM KLOK R VANDERSCHORS R SNOW GB VANDONGEN GAMS
Citation: Fb. Vangog et al., MONOCLONAL-ANTIBODIES LABELED WITH RE-186 USING THE MAG3 CHELATE - RELATIONSHIP BETWEEN THE NUMBER OF CHELATED GROUPS AND BIODISTRIBUTION CHARACTERISTICS, The Journal of nuclear medicine, 37(2), 1996, pp. 352-362
MONOCLONAL-ANTIBODY U36, A SUITABLE CANDIDATE FOR CLINICAL IMMUNOTHERAPY OF SQUAMOUS-CELL CARCINOMA, RECOGNIZES A CD44 ISOFORM
Authors: VANHAL NLW VANDONGEN GAMS ROODKNIPPELS EMC VANDERVALK P SNOW GB BRAKENHOFF RH
Citation: Nlw. Vanhal et al., MONOCLONAL-ANTIBODY U36, A SUITABLE CANDIDATE FOR CLINICAL IMMUNOTHERAPY OF SQUAMOUS-CELL CARCINOMA, RECOGNIZES A CD44 ISOFORM, International journal of cancer, 68(4), 1996, pp. 520-527
THE ROLE OF APOPTOSIS IN ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY AGAINST MONOLAYERS OF HUMAN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK TARGETS
Authors: SUNG MW NAGASHIMA S JOHNSON JT VANDONGEN GAMS WHITESIDE TL
Citation: Mw. Sung et al., THE ROLE OF APOPTOSIS IN ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY AGAINST MONOLAYERS OF HUMAN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK TARGETS, Cellular immunology, 171(1), 1996, pp. 20-29
RADIOIMMUNOSCINTIGRAPHY AND BIODISTRIBUTION OF TC-99M-LABELED MONOCLONAL-ANTIBODY U36 IN PATIENTS WITH HEAD AND NECK-CANCER
Authors: DEBREE R ROOS JC QUAK JJ DENHOLLANDER W SNOW GB VANDONGEN GAMS
Citation: R. Debree et al., RADIOIMMUNOSCINTIGRAPHY AND BIODISTRIBUTION OF TC-99M-LABELED MONOCLONAL-ANTIBODY U36 IN PATIENTS WITH HEAD AND NECK-CANCER, Clinical cancer research, 1(6), 1995, pp. 591-598
BIODISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY E48 IGG AND F(AB'(2)) IN PATIENTS WITH HEAD AND NECK-CANCER
Authors: DEBREE R ROOS JC QUAK JJ DENHOLLANDER W WILHELM AJ VANLINGEN A SNOW GB VANDONGEN GAMS
Citation: R. Debree et al., BIODISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY E48 IGG AND F(AB'(2)) IN PATIENTS WITH HEAD AND NECK-CANCER, Clinical cancer research, 1(3), 1995, pp. 277-286
CONSTRUCTION AND CHARACTERIZATION OF THE CHIMERIC MONOCLONAL-ANTIBODYE48 FOR THERAPY OF HEAD AND NECK-CANCER
Authors: BRAKENHOFF RH VANGOG FB LOONEY JE VANWALSUM M SNOW GB VANDONGEN GAMS
Citation: Rh. Brakenhoff et al., CONSTRUCTION AND CHARACTERIZATION OF THE CHIMERIC MONOCLONAL-ANTIBODYE48 FOR THERAPY OF HEAD AND NECK-CANCER, Cancer immunology and immunotherapy, 40(3), 1995, pp. 191-200
THE HUMAN E48 ANTIGEN, HIGHLY HOMOLOGOUS TO THE MURINE LY-6 ANTIGEN THB, IS A GPI-ANCHORED MOLECULE APPARENTLY INVOLVED IN KERATINOCYTE CELL-CELL ADHESION
Authors: BRAKENHOFF RH GERRETSEN M KNIPPELS EMC VANDIJK M VANESSEN H WEGHUIS DO SINKE RJ SNOW GB VANDONGEN GAMS
Citation: Rh. Brakenhoff et al., THE HUMAN E48 ANTIGEN, HIGHLY HOMOLOGOUS TO THE MURINE LY-6 ANTIGEN THB, IS A GPI-ANCHORED MOLECULE APPARENTLY INVOLVED IN KERATINOCYTE CELL-CELL ADHESION, The Journal of cell biology, 129(6), 1995, pp. 1677-1689
NATURAL-KILLER (NK) CELLS AS EFFECTORS OF ANTIBODY-DEPENDENT CYTOTOXICITY WITH CHIMERIC ANTIBODIES REACTIVE WITH HUMAN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK
Authors: SUNG MW YASUMURA S JOHNSON JT VANDONGEN GAMS WHITESIDE TL
Citation: Mw. Sung et al., NATURAL-KILLER (NK) CELLS AS EFFECTORS OF ANTIBODY-DEPENDENT CYTOTOXICITY WITH CHIMERIC ANTIBODIES REACTIVE WITH HUMAN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK, International journal of cancer, 61(6), 1995, pp. 864-872
PROGRESS IN RADIOIMMUNOTHERAPY OF HEAD AND NECK-CANCER (REVIEW)
Authors: VANDONGEN GAMS BRAKENHOFF RH DEBREE R GERRETSEN M QUAK JJ SNOW GB
Citation: Gams. Vandongen et al., PROGRESS IN RADIOIMMUNOTHERAPY OF HEAD AND NECK-CANCER (REVIEW), Oncology Reports, 1(1), 1994, pp. 259-264
THE FEASIBILITY OF RADIOIMMUNOTHERAPY OF HEAD AND NECK-CANCER
Authors: GERRETSEN M QUAK JJ BRAKENHOFF RH SNOW GB VANDONGEN GAMS
Citation: M. Gerretsen et al., THE FEASIBILITY OF RADIOIMMUNOTHERAPY OF HEAD AND NECK-CANCER, European journal of cancer. Part B, Oral oncology, 30B(2), 1994, pp. 82-87
CLINICAL IMAGING OF HEAD AND NECK-CANCER WITH TC-99M-LABELED MONOCLONAL-ANTIBODY E48 IGG OR F(AB')(2)
Authors: DEBREE R ROOS JC QUAK JJ DENHOLLANDER W VANDENBREKEL MWM VANDERWAL JE TOBI H SNOW GB VANDONGEN GAMS
Citation: R. Debree et al., CLINICAL IMAGING OF HEAD AND NECK-CANCER WITH TC-99M-LABELED MONOCLONAL-ANTIBODY E48 IGG OR F(AB')(2), The Journal of nuclear medicine, 35(5), 1994, pp. 775-783
CLINICAL SCREENING OF MONOCLONAL-ANTIBODIES 323 A3, CSF-25 AND K928 FOR SUITABILITY OF TARGETING TUMORS IN THE UPPER AERODIGESTIVE AND RESPIRATORY-TRACT/
Authors: DEBREE R ROOS JC QUAK JJ DENHOLLANDER W SNOW GB VANDONGEN GAMS
Citation: R. Debree et al., CLINICAL SCREENING OF MONOCLONAL-ANTIBODIES 323 A3, CSF-25 AND K928 FOR SUITABILITY OF TARGETING TUMORS IN THE UPPER AERODIGESTIVE AND RESPIRATORY-TRACT/, Nuclear medicine communications, 15(8), 1994, pp. 613-627
OPTIMIZATION AND SIMPLIFICATION OF EXPRESSION CLONING IN EUKARYOTIC VECTOR HOST SYSTEMS (VOL 218, PG 460, 1994)/
Authors: BRAKENHOFF RH KNIPPELS EMC VANDONGEN GAMS
Citation: Rh. Brakenhoff et al., OPTIMIZATION AND SIMPLIFICATION OF EXPRESSION CLONING IN EUKARYOTIC VECTOR HOST SYSTEMS (VOL 218, PG 460, 1994)/, Analytical biochemistry, 221(2), 1994, pp. 434-434
OPTIMIZATION AND SIMPLIFICATION OF EXPRESSION CLONING IN EUKARYOTIC VECTOR HOST SYSTEMS/
Authors: BRAKENHOFF RH KNIPPELS EMC VANDONGEN GAMS
Citation: Rh. Brakenhoff et al., OPTIMIZATION AND SIMPLIFICATION OF EXPRESSION CLONING IN EUKARYOTIC VECTOR HOST SYSTEMS/, Analytical biochemistry, 218(2), 1994, pp. 460-463
Risultati: 1-25 | 26-27